Research summary ·
Polyarteritis nodosa and antiphospholipid syndrome: a systematic review of a rare and challenging overlap between vasculitis and thrombotic vasculopathy.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This review looked at people who had both PAN and APS. In PAN, the vessel damage comes from inflammation. In APS, the damage comes from blood clots. The team searched large medical databases up to 2026. They gathered all published reports of people with both diseases. The work came from single case reports and small case series.
What they found
Only a few cases were found. Most people were middle-aged men, but one was a child. Often both diseases were found at the same time. In some people, APS came after PAN began. People had signs of PAN, such as nerve damage and high blood pressure. They also had clots that caused stroke, kidney damage or poor limb blood flow. Clot-linked antibodies were often found in the blood. A typical sign was bulging vessels and clots side by side. Treatment usually used steroid drugs and cyclophosphamide. Blood thinners were often added. Results varied, from getting better to losing limbs or dying.
What it means for patients
The authors say this overlap is rare but serious. It mixes vessel inflammation with clotting. They say spotting it matters for how doctors test and treat. Early work hints that vessel lining damage and immune steps may play a part.
Why it is not certain yet
The review found only a few cases. All came from case reports or small case series. The cases differed a lot, so the team only described them. It can be hard to tell inflammation from clots in these people. The authors say more studies are needed on causes and treatment. A review can only be as good as the studies in it.
Source
Polyarteritis nodosa and antiphospholipid syndrome: a systematic review of a rare and challenging overlap between vasculitis and thrombotic vasculopathy.
PubMed · PMID 42377683We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Antiphospholipid syndrome publications